title: Methylprednisolone for status migrainous vertigo and cephalic status migrainosus.
authors.forename: Matthew S
authors.initials: MS
authors.lastname: Robbins
authors.forename: Dong
authors.initials: D
authors.lastname: Wang
authors.forename: Vincent S
authors.initials: VS
authors.lastname: DeOrchis
mesh_terms: D004334:Drug Administration Schedule; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage*; D008875:Middle Aged; D008881:Migraine Disorders / Q000150:complications* / Q000209:etiology* / Q000503:physiopathology; D016896:Treatment Outcome; D014717:Vertigo / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D015837:Vestibular Diseases / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D014725:Vestibular Nerve / Q000187:drug effects / Q000503:physiopathology; D014722:Vestibule, Labyrinth / Q000187:drug effects / Q000503:physiopathology
chemical_list: D005938:Glucocorticoids; D008775:Methylprednisolone